AI assistant
Sending…
Egetis Therapeutics — Major Shareholding Notification 2020
Nov 11, 2020
3152_iss_2020-11-11_d5a8fb1c-3b6a-4330-b99f-bae0a8e427b2.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer Egetis Therapeutics AB (publ)
Holder
Cidro Förvaltning AB
Instrument
| Instrument | Aktie |
|---|---|
| Before the transaction | |
| Shares | 6,767,379 |
| Voting rights | 6,767,379 |
| Transaction | |
| Reason for major shareholding notification Sell | |
| Date | 10/11/2020 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 5,367,379 |
| Directly held voting rights | 5,367,379 |
| Indirectly held voting rights | 5,367,379 |
| Percentage | |
| Directly held shares | 4.6 % |
| Directly held voting rights | 4.6 % |
| Indirectly held voting rights | 4.6 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 9.2 % | 5,367,379 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 9.2 % | 5,367,379 |
| Published | ||
| 11/11/2020 13:16 | ||
| Contact | ||
| Name Peter Lindell |
||
| Phone 0708496659 Email [email protected] |
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Egetis Therapeutics
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Share Issue/Capital Change
2026
Apr 21
Share Issue/Capital Change
2026
Apr 21
Share Issue/Capital Change
2026
Apr 21
Share Issue/Capital Change
2026
Apr 21
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 14
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 14